About Mscamino Pharma Private Limited
Data last updated: 06 February 2026
Mscamino Pharma Private Limited is a private limited company based in Bangalore South, Karnataka, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 November 2022.
Registered with ROC Bangalore under CIN U24110KA2022PTC167589.
Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rohan Mehta and Tarun Mehta.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Bangalore South, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹52,000.
The company has a workforce of approximately 12 employees as per the latest available data.
The company is associated with 1 brand - Msc Amino Pharma. As per MCA filings, the company has open charges of ₹4.99 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mscamino.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressSuryakirana No. 27, Jyothi Nagar Mysore Road, Bangalore South, Karnataka, India – 560039
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Mscamino Pharma Private Limited
Mscamino Pharma Private Limited operates one associated brand: MSC Amino Pharma. These brands represent Mscamino Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality amino acids and pharmaceutical products for the industry. | mscamino.com |
Competitors & Alternatives of Mscamino Pharma Private Limited
Brands and companies operating in the same space as Mscamino Pharma Private Limited include Enzene Biosciences, Hybio Pharmaceutical, PolyPeptide and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Enzene Biosciences
|
Company specializing in development of Biosimilars | Pune, India, India | 2006 |
Hybio Pharmaceutical
|
Polypeptide drugs and APIs are developed and manufactured. | Shenzhen, China, China | 1998 |
PolyPeptide
|
Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs. | Baar, Switzerland, Switzerland | 1952 |
AmbioPharm
|
CDMO and analytical services for peptide development are provided. | North Augusta, United States, United States | 2006 |
vivitide
|
Drug development services for neoantigen peptides and antibodies are provided. | Gardner, United States, United States | 1983 |
Shaanxi Micot Technology
|
Drug R&D services for cardiovascular and metabolic diseases are provided. | China | 2007 |
Aperiam Bio
|
Industrial and therapeutic proteins are manufactured by Aperiam Bio. | United States | 2019 |
Rameda
|
Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products | Giza, Egypt, Egypt | 1994 |
Ocelot Bio
|
Ocelot Bio is a CDMO specializing in peptide manufacturing services. | San Diego, United States, United States | 2020 |
Maruho
|
Conducts R&D and manufactures ethical drugs for healthcare applications. | Osaka, Japan, Japan | 1915 |
Business Activity of Mscamino Pharma Private Limited
Mscamino Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Mscamino Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Mscamino Pharma Private Limited
Mscamino Pharma Private Limited is audited by Sundararajan & Harish CharteredAccountants for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sundararajan & Harish CharteredAccountants | Locked | Locked | Locked |
Complete auditor history for Mscamino Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mscamino Pharma Private Limited
Mscamino Pharma Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rohan Mehta
Also directs:
Kiayaxanime Private Limited
|
Director | 02 Nov 2022 | 3 Years 8 Months | Current |
|
Tarun Mehta
Also directs:
Msc Nutra Private Limited
|
Whole-Time Director | 02 Nov 2022 | 3 Years 8 Months | Current |
Financials of Mscamino Pharma Private Limited FY 2024 filings available
Mscamino Pharma Private Limited reported revenue of ₹52,000 for FY 2024.
Ten-year financial statements for Mscamino Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Mscamino Pharma Private Limited
Shareholding and ownership data for Mscamino Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mscamino Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2023 | State Bank of India | ₹9 Lakh | Open |
| 24 Aug 2023 | State Bank of India | ₹4.9 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Mscamino Pharma Private Limited
View historical data on people associated with Mscamino Pharma Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Mscamino Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Mscamino Pharma Private Limited
GST registrations and filing compliance for Mscamino Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Mscamino Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Mscamino Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mscamino Pharma Private Limited
MSME payment history for Mscamino Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mscamino Pharma Private Limited
Corporate group structure for Mscamino Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mscamino Pharma Private Limited
MCA filings and documents for Mscamino Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Mscamino Pharma Private Limited
Frequently Asked Questions about Mscamino Pharma Private Limited
Mscamino Pharma Private Limited is an active private limited company in the pharma sector based in Bangalore South, Karnataka, India. It was incorporated on 02 November 2022 (4+ years old) and is registered under CIN U24110KA2022PTC167589. The company has 12 employees.
Mscamino Pharma Private Limited reported revenue of ₹52,000 for FY 2024.
The current directors of Mscamino Pharma Private Limited are:
- Rohan Mehta - Director
- Tarun Mehta - Whole-Time Director
The primary industry of Mscamino Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Mscamino Pharma Private Limited can be reached at the registered office: Suryakirana No. 27, Jyothi Nagar Mysore Road, Bangalore South, Karnataka, India – 560039, or through the website mscamino.com.
The authorised capital is ₹10 Lakh, and the paid-up capital is ₹1 Lakh.